Description

5‑Amino‑1MQ (5-amino-1-methylquinolinum) is a small‑molecule compound known for inhibiting the enzyme NNMT (nicotinamide‑N‑methyltransferase). NNMT plays a role in energy metabolism and fat storage, and its overactivity is linked to obesity, metabolic dysfunction, and reduced NAD+ availability.

Key information and effects:

• NNMT inhibition: By blocking NNMT, 5‑Amino‑1MQ may increase cellular NAD⁺ levels, supporting better energy production and metabolic function.

• Fat‑loss support: Research suggests it can reduce the size of fat cells (adipocytes) and decrease fat accumulation, potentially aiding in weight management.

• Enhanced energy metabolism: Increased NAD⁺ availability can improve mitochondrial efficiency and cellular energy output.

• Muscle preservation: Some early studies indicate weight loss from 5‑Amino‑1MQ may spare muscle tissue while reducing fat mass.

• Anti‑inflammatory effects: NNMT inhibition may reduce inflammatory signaling associated with obesity and metabolic syndrome.

• Cognitive and cellular benefits: Higher NAD⁺ levels are linked to improved cellular repair, mitochondrial health, and potentially enhanced cognitive function